A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 325
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PS
Long Form : permeability-surface area product
No. Year Title Co-occurring Abbreviation
2018 Blood-Brain Barrier Permeability in Aneurysmal Subarachnoid Hemorrhage: Correlation With Clinical Outcomes. BBBP, EES, SAH
2018 CT perfusion in normal liver and liver metastases from neuroendocrine tumors treated with targeted antivascular agents. BF, BV, CTP, HAF, mNET, MTT
2018 Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. BF, BV, MDCT, MFCP, MTT, PCT, PDAC
2018 Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion. AML, AUC, BF, NPV, PPV, RCC, ROC
2018 Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time. BBB, EPM, Fp, PM
2018 Non-contrast MR imaging of blood-brain barrier permeability to water. BBB, LL, PLD, SSS, WEPCAST
2018 Perfusion Computer Tomography Assessment of the Effect of Angiotensin II On Blood Flow Distribution in Rabbits with Intrarenal VX2 Tumors. BF, BV, CDT, CT, MTT, rPS, RRC
2017 Adaptive statistical iterative reconstruction improves image quality without affecting perfusion CT quantitation in primary colorectal cancer. ASIR, BF, BV, CNR, CV, MTT, PCT, RANOVA
2017 Carotid Artery Stenting and Blood-Brain Barrier Permeability in Subjects with Chronic Carotid Artery Stenosis. BBB, CBF, CBV, CTP, MTT, TTP
10  2017 Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature. CD105-MVD, DCE-MRI, PCT
11  2017 Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma. BF, RCC
12  2017 Differentiation of low- and high-grade clear cell renal cell carcinoma: Tumor size versus CT perfusion parameters. BF, Equiv BV, RCC
13  2017 Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma. BF, BV, mRCC, OS, PFS
14  2017 Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis. CBF, CBV, DCE, MRI, MS, NAWM, RR
15  2017 Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and 99mTc-tetrofosmin: Method and validation. CFR, MBF, PET, SPECT
16  2017 Permeability surface area product analysis in malignant brain edema prediction - A pilot study. CBF, CBV
17  2017 Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide. GBM, KPS, LTSs, MGMT, PCT, TMZ
18  2017 Quantification of blood-brain barrier permeability by dynamic contrast-enhanced NIRS. BBB, CT, DCE, NIRS
19  2017 Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study. AUROC, DCE-MRI, SD, Vb, ve
20  2017 Quantitative assessment on blood-brain barrier permeability of acute spontaneous intracerebral hemorrhage in basal ganglia: a CT perfusion study. BBB, CTP, ICH
21  2017 Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage. BBB, CTP, MMP, rt-PA, STS, TIMP
22  2017 The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability. DCE-MRI, Fp
23  2017 [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma]. DCE-MRI
24  2016 Comparison of distributed and compartmental models of drug disposition: assessment of tissue uptake kinetics. ---
25  2016 Correlation of volumetric perfusion CT parameters with hypoxia inducible factor-1 alpha expression in a rabbit VX2 tumor model. BF, BV, CT, HIF-1alpha, MVD
26  2016 Does computed tomography permeability predict hemorrhagic transformation after ischemic stroke? AIS, CT, rPS
27  2016 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma. 2CXM, Fp, HCC, HPI, ve, vp
28  2016 Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia. BF, BV, CT, SRS, TV
29  2016 Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum? BF, BV, MFCP, MTT, PCT, PEI, TTP
30  2015 Blood-brain barrier compromise does not predict perihematoma edema growth in intracerebral hemorrhage. BBB, SBP
31  2015 DCE-MRI biomarkers for monitoring an anti-angiogenic triple combination therapy in experimental hypopharynx carcinoma xenografts with immunohistochemical validation. DCE, HNSCC, MRI, TBF, tBV
32  2015 Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability. DCE-MRI, Fp, RCC, ROI, sROI, VE, Vp
33  2015 Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma: A Pilot Comparative Study. 1Y-S, AATH, DCE-MRI, DP, HCC, OS, TK
34  2015 Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage. BBB, CFA, CNS, IS, TG
35  2015 Influence of Thin Slice Reconstruction on CT Brain Perfusion Analysis. AIF, CBF, CBV, CTP, MTT
36  2015 Possibilities of differentiation of solitary focal liver lesions by computed tomography perfusion. BF, BV, CT, HAF, HPI, IRF, MTT
37  2015 Standardized perfusion value of the esophageal carcinoma and its correlation with quantitative CT perfusion parameter values. BF, BV, MTT, rs, SPV
38  2014 Correlations between CT perfusion parameters and vascular endothelial growth factor expression and microvessel density in implanted VX2 lung tumors. BF, BV, MAV
39  2014 Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them? DCE, DSC, IVIM
40  2014 Does the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary study. BF, BV, CT, MTT, NACRT, pCR
41  2014 Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts. DCE, micro-CT, MVD, RBV, rVV, UM
42  2014 Effect of increasing the sampling interval to 2 seconds on the radiation dose and accuracy of CT perfusion of the head and neck. CT
43  2014 Improving quantitative CT perfusion parameter measurements using principal component analysis. BF, BV, CI, CNR, CT, PCA
44  2014 Increased blood-brain barrier permeability on perfusion computed tomography predicts hemorrhagic transformation in acute ischemic stroke. CT, HT
45  2014 Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. DCE-MRI, DWI, EES, Fb, MVD
46  2014 Multiparametric monitoring of early response to antiangiogenic therapy: a sequential perfusion CT and PET/CT study in a rabbit VX2 tumor model. BF, BV, FMR, MVD, TLG
47  2014 Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients. BF, BV, GS, MTT, PCa, PCT, PZ
48  2014 Role of Perfusion CT Differentiating Hemangiomas from Malignant Hepatic Lesions. BF, BV, CT, HAF, HCC, IRFTO, MDCT, MTT, NPV, PPV
49  2014 Study of 320-slice dynamic volume CT perfusion in different pathologic types of kidney tumor: preliminary results. AML, BF, Equiv BV, RCC
50  2014 Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer. 2CXM, C-TU, DCE-MRI, TKMs, ve, vp
51  2014 Value of perfusion CT parameters, microvessl density and VEGF expression in differentiation of benign and malignant prostate tumours. BF, BV, CTP, MTT, MVD, VEGFLI
52  2014 Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy. ---
53  2013 Classic models for dynamic contrast-enhanced MRI. BBB, CBF, CBV, DCE-MRI, ve
54  2013 Combined arterial spin labeling and diffusion-weighted imaging for noninvasive estimation of capillary volume fraction and permeability-surface product in the human brain. ASL, CBF, DWI
55  2013 Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma. ADC, BOLD, DCE, DWI, Fp, MRI, RCC, VE, Vp
56  2013 Correlation between CT perfusion parameters and microvessel density and vascular endothelial growth factor in adrenal tumors. BF, BV, CT, IQR, MTT, MVD, VEGF
57  2013 Differences in perfusion CT parameter values with commercial software upgrades: a preliminary report about algorithm consistency and stability. BF, BV, CT Perfusion 4D, CTp, MTT
58  2013 Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. ADC, DCE-MRI, DWI, EES, Fb, Tc, Vb, Ve
59  2013 Evaluating the effect of high-intensity focused ultrasound therapy on liver tumors using multislice CT perfusion. CTP, HBF, HBV, HIFU, MSCT, MTT
60  2013 Evaluation of perfusion CT in grading and prognostication of high-grade gliomas at diagnosis: a pilot study. AUC, CBV, HGGs
61  2013 In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media. DCE-MRI, MMCM
62  2013 Investigation on the optical scan condition for imaging of multi-slice spiral CT liver perfusion in rats. HAI, HAP, HBF, HBV, HPP, MTT, TDCs
63  2013 Modeling serotonin uptake in the lung shows endothelial transporters dominate over cleft permeation. EC
64  2013 Perfusion CT vascular parameters do not correlate with immunohistochemically derived microvessel density count in colorectal tumors. CT, MTT, MVD, ROIs
65  2013 Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates. OS, PCT, rCBV, WHO
66  2013 The effect of scan duration on the measurement of perfusion parameters in CT perfusion studies of brain tumors. BF, BV, CT
67  2013 The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols. BBB, BMC, fu, IAM, Kma, LSER, PCA, Vm
68  2012 Comparison of CT perfusion parameters and microvessel density in intracranial hemangiopericytomas with peritumoral edema. CBV, CTP, HPCs, MVD
69  2012 CT perfusion measurements of head and neck carcinoma from single section with largest tumor dimensions or average of multiple sections: agreement between the two methods and effect on intra- and inter-observer agreement. BF, BV, MTT, ROI, SCC
70  2012 Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications. CT, CTP
71  2012 Perfusion CT assessment of the colon and rectum: feasibility of quantification of bowel wall perfusion and vascularization. BF, BV, MTT
72  2012 Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. CBF, CBV, CE, DCE, MS, NAWM
73  2012 Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use. BF, BV, CT, HCC, ICCs, LOA, MTT
74  2012 Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. AUROC, DCE-MRI, Vb, ve
75  2012 Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. BF, BV, DCE-MRI, MTT
76  2012 Role of perfusion CT in differentiating between various cerebral masses using normalized permeability surface area product and cerebral blood volume. CBV
77  2012 The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer. BF, BV, MTT
78  2012 Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer. BF, BV, CRT, CT, MTT
79  2011 64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters. BF, BV, CT, MTT, ROI, SCC
80  2011 Acute lung injury and pulmonary vascular permeability: use of transgenic models. ---
81  2011 Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging. BF, BV, CT
82  2011 Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. BBB, Tf-PO
83  2011 Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor. BF, BV, MVD, TACE, VEGF
84  2011 Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. BF, BV, MTT
85  2011 Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas. CBF, CBV, CE, MVCP, MVD, NE, PCT, VEGFR2, WHO
86  2011 Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. NASH
87  2011 Reproducibility of CT perfusion parameters in liver tumors and normal liver. BF, BV, CT, CVs, MTT
88  2011 The Use of CT Perfusion to Determine Microvessel Density in Lung Cancer: Comparison with FDG-PET and Pathology. BF, BV, MTT, MVD, SUVs, TDC, TPH
89  2010 Angiogenesis of renal cell carcinoma: perfusion CT findings. BF, BV, MTT, RCC
90  2010 Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? CBV, TDLs
91  2010 Dynamic contrast-enhanced MR imaging to assess physiologic variations of myometrial perfusion. DCE-MRI
92  2010 Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging. 64MDCT, BF, BV, MTT, MVD, ROI, TDC, VEGF
93  2010 First-pass perfusion computed tomography: initial experience in differentiating adrenal adenoma from metastasis. BF, BV, MTT, MVD, PCT
94  2010 Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion. BF, BV, CTP, HAPI, MTT
95  2010 Perfusion CT findings in liver of patients with tumor during chemotherapy. CT, HPI, MTT
96  2010 Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood. PBPK
97  2010 [Advanced NSCLC first pass perfusion at 64-slice CT: reproducibility of volume-based quantitative measurement]. BF, BV, CTP, ICC, MTT, NSCLC, RC
98  2010 [Application of 64MDCT multislice perfusion imaging in colorectal carcinoma]. 64MDCT, BF, BV, CRC, MTT, ROI, TDC
99  2009 Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy. DCE-MRI, GDCC-40
100  2009 Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography. CT, MTT